VARIATION ANALYSIS OF HPV16 CELL-TYPE-SPECIFIC ENHANCER IN CERVICAL CARCINOMA
- Author:
Wenkang LIU
;
Yonglie CHU
;
Tianyou MA
;
E YANG
;
Chunxia CAO
- Publication Type:Journal Article
- Keywords:
cervical carcinoma;
HPV16;
cell-type-specific enhancer;
PCR-SSCP;
variation
- From:
Journal of Pharmaceutical Analysis
2006;18(2):171-173
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the cell-type-specific enhancer (CTSE) in HPV16 and its variation in cervical carcinoma. Methods CTSEs were detected by polymerase chain reaction (PCR) in 58 cervical carcinoma from Shaanxi province; in addition variation of CTSEs was analyzed through single-strand conformation polymorphisms (SSCP). Results HPV16 CTSEs were detectable in 34 of 58 (57%) specimens and mutant rate was 41%(14/34) and the main mutations of chosen randomly variant CTSE (CTSEv) happened at YY1 binding sites in addition to glucocoticoid response elements (GRE). Conclusion CTSE in some specimens of Shaanxi province was obviously different from that in HPV16 wild type and variant CTSE might affect the transcriptional regulation of LCR on viral P97, which regulates over-expression of viral oncogenes in cervical carcinoma.
